Skinvisible (SKVI) Cash & Equivalents (2011 - 2026)
Skinvisible's (SKVI) quarterly Cash & Equivalents came in at $3959.0 in Q2 2026, up 3199.17% year-over-year from $120.0 in Q2 2025, and up 120.19% quarter-over-quarter from $1798.0 in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) Cash & Equivalents (2011 - 2026) Analysis & Trends
Skinvisible has disclosed Cash & Equivalents across 16 years of filings, most recently posting $3959.0 for Q2 2026.
- In Q2 2026, Cash & Equivalents rose 3199.17% year-over-year to $3959.0; the TTM figure through Jun 2026 stood at $3959.0 (up 3199.17% YoY), while the FY2025 annual figure was $2620.0, down 74.65% from the prior year.
- Cash & Equivalents came in at $3959.0 for Q2 2026 at Skinvisible, up from $1798.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $160336.0 in Q2 2022 to a low of $120.0 in Q2 2025.
- Average Cash & Equivalents over 5 years is $26505.7, with a median of $5474.5 recorded in 2024.
- Year-over-year, Cash & Equivalents slumped 99.43% in 2023 and surged 3199.17% in 2026.
- Over 5 years, Cash & Equivalents stood at $81378.0 in 2022, then slumped by 98.91% to $888.0 in 2023, then jumped by 1063.96% to $10336.0 in 2024, then tumbled by 74.65% to $2620.0 in 2025, then soared by 51.11% to $3959.0 in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $3959.0 in Q2 2026, $1798.0 in Q1 2026, and $2620.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn | 976.00 Mn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | 7.38 Bn |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - | 815.44 Mn |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn | 3.98 Bn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn | 1.80 Bn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 3,959.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,959.00 |
| Mar 31, 2026 | 1,798.00 |
| Dec 31, 2025 | 2,620.00 |
| Sep 30, 2025 | 645.00 |
| Jun 30, 2025 | 120.00 |
| Mar 31, 2025 | 13,396.00 |
| Dec 31, 2024 | 10,336.00 |
| Sep 30, 2024 | 612.00 |
| Jun 30, 2024 | 6,990.00 |
| Mar 31, 2024 | 8,097.00 |
| Dec 31, 2023 | 888.00 |
| Sep 30, 2023 | 731.00 |
| Jun 30, 2023 | 3,548.00 |
| Mar 31, 2023 | 29,138.00 |
| Dec 31, 2022 | 81,378.00 |
| Sep 30, 2022 | 127,413.00 |
| Jun 30, 2022 | 160,336.00 |
| Mar 31, 2022 | 25,097.00 |
| Dec 31, 2021 | 66,037.00 |
| Sep 30, 2021 | 49,223.00 |